AU746411B2 - Preparation of glycosylated tumor necrosis factor - Google Patents

Preparation of glycosylated tumor necrosis factor Download PDF

Info

Publication number
AU746411B2
AU746411B2 AU75466/98A AU7546698A AU746411B2 AU 746411 B2 AU746411 B2 AU 746411B2 AU 75466/98 A AU75466/98 A AU 75466/98A AU 7546698 A AU7546698 A AU 7546698A AU 746411 B2 AU746411 B2 AU 746411B2
Authority
AU
Australia
Prior art keywords
tnf
glycosylated
necrosis factor
tumor necrosis
alpha
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU75466/98A
Other languages
English (en)
Other versions
AU7546698A (en
Inventor
Adrian Harel
Ziva Messika
Menachem Zeevi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Interpharm Laboratories Ltd
Original Assignee
Interpharm Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Interpharm Laboratories Ltd filed Critical Interpharm Laboratories Ltd
Publication of AU7546698A publication Critical patent/AU7546698A/en
Application granted granted Critical
Publication of AU746411B2 publication Critical patent/AU746411B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/525—Tumour necrosis factor [TNF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Transplantation (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Emergency Medicine (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AU75466/98A 1997-06-02 1998-06-01 Preparation of glycosylated tumor necrosis factor Ceased AU746411B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IL12097997A IL120979A0 (en) 1997-06-02 1997-06-02 Glycosylated TNF
IL120979 1997-06-02
PCT/IL1998/000254 WO1998055622A1 (en) 1997-06-02 1998-06-01 Preparation of glycosylated tumor necrosis factor

Publications (2)

Publication Number Publication Date
AU7546698A AU7546698A (en) 1998-12-21
AU746411B2 true AU746411B2 (en) 2002-05-02

Family

ID=11070212

Family Applications (1)

Application Number Title Priority Date Filing Date
AU75466/98A Ceased AU746411B2 (en) 1997-06-02 1998-06-01 Preparation of glycosylated tumor necrosis factor

Country Status (6)

Country Link
EP (1) EP0985040A1 (ja)
JP (1) JP2002502257A (ja)
AU (1) AU746411B2 (ja)
CA (1) CA2289564A1 (ja)
IL (1) IL120979A0 (ja)
WO (1) WO1998055622A1 (ja)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6579522B1 (en) 2000-06-27 2003-06-17 Genvec, Inc. Replication deficient adenoviral TNF vector
US20030086903A1 (en) 2001-11-02 2003-05-08 Genvec, Inc. Therapeutic regimen for treating cancer
JP2008528006A (ja) * 2005-01-28 2008-07-31 アポロ ライフ サイエンシズ リミテッド 分子およびそのキメラ分子

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0168214A2 (en) * 1984-07-05 1986-01-15 Genentech, Inc. Tumor necrosis factor, methods for its preparation, compositions containing it, DNA encoding it and assay method using such DNA
WO1988006625A2 (en) * 1987-02-26 1988-09-07 Cetus Corporation Arginine-depleted human tumor necrosis factor
US5378603A (en) * 1987-03-30 1995-01-03 Board Of Regents, The University Of Texas System Method and composition for identifying substances which activate transcription of the LDL receptor gene

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0168214A2 (en) * 1984-07-05 1986-01-15 Genentech, Inc. Tumor necrosis factor, methods for its preparation, compositions containing it, DNA encoding it and assay method using such DNA
WO1988006625A2 (en) * 1987-02-26 1988-09-07 Cetus Corporation Arginine-depleted human tumor necrosis factor
US5378603A (en) * 1987-03-30 1995-01-03 Board Of Regents, The University Of Texas System Method and composition for identifying substances which activate transcription of the LDL receptor gene

Also Published As

Publication number Publication date
AU7546698A (en) 1998-12-21
WO1998055622A1 (en) 1998-12-10
EP0985040A1 (en) 2000-03-15
JP2002502257A (ja) 2002-01-22
IL120979A0 (en) 1997-11-20
CA2289564A1 (en) 1998-12-10

Similar Documents

Publication Publication Date Title
RU2736339C9 (ru) Слитый белок человеческого фактора свертывания IХ (FIX), способ его получения и применения
RU2722374C1 (ru) Высокогликозилированный слитый белок на основе фактора свертывания крови человека viii, способ его получения и его применение
JP2804237B2 (ja) 組換えリンホトキシンをコードするｄｎａ
US4650674A (en) Synergistic cytotoxic composition
JP6231056B2 (ja) 組換えｆｓｈを精製する方法
CN102656182B (zh) 纯化糖蛋白的方法
US6433142B1 (en) Megakaryocyte stimulating factors
EA017733B1 (ru) СПОСОБ ОЧИСТКИ Fc-СЛИТЫХ БЕЛКОВ
IL105271A (en) Tumor nectosis factor and variants
AU2008314687A1 (en) Method for purifying Fc-fusion proteins
JPH11507033A (ja) トロンボポイエチンを精製する方法
CN113105562A (zh) 突变型单链人凝血因子viii在制备融合蛋白中的应用
CA1335360C (en) Recombinant natural killer cell activator
AU746411B2 (en) Preparation of glycosylated tumor necrosis factor
CN103044554B (zh) 重组二聚化人尿胰蛋白酶抑制剂、其制备方法及其应用
KR20220143676A (ko) 정제 방법
IL104297A (en) Lymphotoxin Nucleic acid encoding vectors containing the nucleic acid and cells converted by them Methods for obtaining lymphotoxin

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)